Competitive Analysis
Milliman MACVAT
The Milliman MACVAT supports numerous analyses performed by Milliman experts.
We highlight changes in value added and key benefit trends for general enrollment plans in the Medicare Advantage market from 2025 to 2026.
Are Medicare Advantage prescription drug plans with a zero-dollar member premium worth the effort? We measure the impact on enrollment when premium is added.
D-SNP market experiencing slower growth amid broader Medicare Advantage market and regulatory changes.
In our review of the state of the 2025 Medicare Advantage industry, we highlight changes in value-added and key benefit trends.
We examine changes in value-added and key-benefit trends in the Medicare Advantage market from 2024 to 2025, with a focus on dual-eligible special needs plans.
The 2025 Medicare Advantage (MA) and Part D (MA-PD) bidding cycle brought unprecedented challenges with a redesigned Part D benefit, MA revenue pressures, and rising healthcare trends.
We highlight changes in value added and key benefit trends in the Medicare Advantage market from 2023 to 2024, with a focus on general enrollment plans.
We review changes in value added and key benefit trends in the Medicare Advantage market from 2023 to 2024, with a focus on Dual Eligible Special Needs Plans.
This analysis focuses on mandatory supplemental benefits offered by general enrollment plans from 2019 to 2023.
This analysis focuses on mandatory supplemental benefits offered by Dual Eligible Special Needs Plans (D-SNPs) from 2019 to 2023.
Using Milliman MACVAT®, we analyzed 2023 Medicare Advantage plans to determine the breadth of combo offerings available to beneficiaries.
Lower premiums, richer supplemental benefits, and additional flexibility help drive enrollment gains in an increasingly competitive Medicare Advantage market.
In an increasingly competitive Medicare Advantage (MA) marketplace, supplemental benefits are one of the primary ways Medicare Advantage organizations (MAOs) can differentiate their plans from competitors’ plans.
In an increasingly competitive Medicare Advantage (MA) marketplace, supplemental benefits are one of the primary ways Medicare Advantage organizations (MAOs) can differentiate their plans from competitors’ plans.
The 2022 benefit landscape in the Medicare Advantage (MA) market includes an increase in the number of beneficiaries covered by plans offering combined benefits under a specific maximum plan benefit amount—known as a Combined Benefit Limit or a “combo” benefit.
This paper discusses OSBs offered by MAOs in general enrollment plans from 2017 to 2021.
COVID-19 creates a compelling environment for Medicare Advantage telehealth offerings
This analysis focuses on mandatory supplemental benefits offered by Dual Eligible Special Needs Plans (D-SNPs) from 2017 to 2021.
This report highlights key changes in member premiums and benefits for the 2020 Medicare Advantage (MA) market, as well as the contributing factors for, and the magnitude of, the increase in value added within the MA market each year from 2016 to 2020.
This paper provides insight into benefit and premium changes made alongside revenue changing due to a star rating change and measures the change in value added through benefits and premium changes provided to beneficiaries.
What happens to membership in Medicare Advantage-Prescription Drug plans with a zero-dollar premium when a premium is added?
One innovation that is driving enrollment growth for some Medicare Advantage organizations is the $0 member premium PPO.
Organizations entering the Medicare Advantage market should be aware of the current star rating climate as well as short- and long-term star rating and revenue considerations.
This paper analyzes historical enrollment experience for parent organizations new to the Medicare Advantage market from 2007 to 2018.